Intellia Therapeutics (NTLA) Current Deferred Revenue (2015 - 2026)
Intellia Therapeutics (NTLA) posted Current Deferred Revenue of $630,000 for Q1 2026, down 97.0% from $20.66 million a year earlier and down 91.4% from the prior quarter.
Powered by 
Analysis
Intellia Therapeutics (NTLA) Current Deferred Revenue (2015 - 2026) Analysis & Trends
At the end of FY2025, Intellia Therapeutics' Current Deferred Revenue came in at $7.29 million, down 64.7% from FY2024.
- Annual Current Deferred Revenue has declined for four consecutive years, with a five-year compound annual growth rate of -20.2% (FY2020 to FY2025).
- In prior years, Intellia Therapeutics' Current Deferred Revenue was $20.66 million in FY2024 (-6.7%), $22.14 million in FY2023 (-49.5%), $43.84 million in FY2022 (-31.2%) and $63.76 million in FY2021 (+182.8%).
- The Q1 2026 figure stands as the lowest quarterly Current Deferred Revenue in data going back to Q4 2015.
- On a year-over-year basis, Current Deferred Revenue has declined in each of the last six quarters, with an average decline of 21.9% over the last eight quarters.
- The strongest year-over-year quarter for Current Deferred Revenue in the past five years was Q1 2022, with growth of 182.8%; the weakest was Q1 2026, with a decline of 97.0%.
- According to Business Quant data, Current Deferred Revenue for the three prior quarters was $7.29 million (Q4 2025), $12.25 million (Q3 2025) and $17.15 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Intellia Therapeutics | 1.69 Bn | 1.69 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 630,000.00 |
| Dec 31, 2025 | 7.29 Mn |
| Sep 30, 2025 | 12.25 Mn |
| Jun 30, 2025 | 17.15 Mn |
| Mar 31, 2025 | 20.66 Mn |
| Dec 31, 2024 | 20.66 Mn |
| Sep 30, 2024 | 22.16 Mn |
| Jun 30, 2024 | 22.18 Mn |
| Mar 31, 2024 | 22.18 Mn |
| Dec 31, 2023 | 22.14 Mn |
| Sep 30, 2023 | 13.35 Mn |
| Jun 30, 2023 | 21.93 Mn |
| Mar 31, 2023 | 35.34 Mn |
| Dec 31, 2022 | 43.84 Mn |
| Sep 30, 2022 | 54.82 Mn |
| Jun 30, 2022 | 61.81 Mn |
| Mar 31, 2022 | 63.76 Mn |
| Dec 31, 2021 | 63.76 Mn |
| Sep 30, 2021 | 56.76 Mn |
| Jun 30, 2021 | 22.54 Mn |
API Access
Intellia Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=NTLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "NTLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=NTLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();